Tauriga Sciences, Inc.
TAUG · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.12 | -0.01 | -0.01 | 0.55 |
| FCF Yield | -11.65% | -57.52% | -2.92% | 12.88% |
| EV / EBITDA | -6.67 | -1.61 | -10.62 | -1.13 |
| Quality | ||||
| ROIC | -239.66% | -756.03% | -151.29% | 4,360.70% |
| Gross Margin | 43.00% | 15.88% | 35.02% | 39.81% |
| Cash Conversion Ratio | 0.70 | 0.50 | 0.30 | -7.19 |
| Growth | ||||
| Revenue 3-Year CAGR | 70.93% | 482.16% | – | – |
| Free Cash Flow Growth | -69.89% | -343.78% | -233.34% | 139.21% |
| Safety | ||||
| Net Debt / EBITDA | -0.15 | -0.32 | 0.16 | -0.12 |
| Interest Coverage | -3.10 | -2.26 | -3.86 | -6.50 |
| Efficiency | ||||
| Inventory Turnover | 0.81 | 1.53 | 3.42 | 0.00 |
| Cash Conversion Cycle | -384.26 | 163.78 | -236.52 | -15,067.26 |